Search

Current COVID-19 vaccines need to take at least one month to complete inoculation and then become effective. Around 51% global population are still not fully vaccinated. Instantaneous protection is an unmet need among those who are not fully vaccinated. In addition, breakthrough infections caused by SARS-CoV-2 are widely reported. All these highlight the unmet needing for short-term instantaneous prophylaxis (STIP) in the communities where SARS-CoV-2 is circulating. Previously, we reported nanobodies isolated from an alpaca immunized with the spike protein, exhibiting ultrahigh potency against SARS-CoV-2 and its variants. Herein, we found that Nb22, among our previously reported nanobodies, exhibited ultrapotent neutralization against Delta variant with an IC50 value of 0.41 ng/ml (5.13 pM). Furthermore, the crystal structural analysis revealed that the binding of Nb22 to WH01 and Delta RBDs both effectively blocked the binding of RBD to hACE2. Additionally, intranasal Nb22 exhibited protection against SARS-CoV-2 Delta variant in the post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP). Of note, intranasal Nb22 also demonstrated high efficacy against SARS-CoV-2 Delta variant in STIP for seven days administered by single dose and exhibited long-lasting retention in the respiratory system for at least one month administered by four doses, providing a means of instantaneous short-term prophylaxis against SARS-CoV-2. Thus, ultrahigh potency, long-lasting retention in the respiratory system as well as stability at room-temperature make the intranasal or inhaled Nb22 to be a potential therapeutic or STIP agent against SARS-CoV-2.Brief summaryNb22 exhibits ultrahigh potency against Delta variant in vitro and is exploited by crystal structural analysis; furthermore, animal study demonstrates high effectiveness in the treatment and short-term instantaneous prophylaxis in hACE2 mice via intranasal administration.HighlightsNb22 exhibits ultrapotent neutralization against Delta variant with an IC50 value of 0.41 ng/ml (5.13 pM).Structural analysis elucidates the ultrapotent neutralization of Nb22 against Delta variant.Nb22 demonstrates complete protection in the treatment of Delta variant infection in hACE2 transgenic mice.We complete the proof of concept of STIP against SARS-CoV-2 using intranasal Nb22 with ultrahigh potency and long-lasting retention in respiratory system.Graphic Abstract

Chimeric antigen receptor (CAR) T-cell therapy is the most active field in immuno-oncology and brings substantial benefit to patients with B cell malignancies. However, the complex procedure for CAR T-cell generation hampers its widespread applications. Here, we describe a novel approach in which human CAR T cells can be generated within the host upon injecting an Adeno-associated virus (AAV) vector carrying the CAR gene, which we call AAV delivering CAR gene therapy (ACG). Upon single infusion into a humanized NOD.Cg-Prkdcscid Il2rgem26/Nju tumor mouse model of human T-cell leukemia, AAV generates sufficient numbers of potent in vivo CAR cells, resulting in tumor regression; these in vivo-generated CAR cells produce antitumor immunological characteristics. This instantaneous generation of in vivo CAR T cells may bypass the need for patient lymphodepletion, as well as the β processes of traditional CAR T-cell production, which may make CAR therapy simpler and less expensive. It may allow the development of intricate, individualized treatments in the form of on-demand and diverse therapies.

The dramatically expanding coronavirus disease 2019 (COVID-19) needs multiple effective countermeasures. Neutralizing nanobodies (Nbs) are a potential therapeutic strategy for treating COVID-19. Here, we characterize several receptor binding domain (RBD)-specific Nbs isolated from an Nb library derived from an alpaca immunized with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein (S); among them, three Nbs exhibit picomolar potency against SARS-CoV-2 live virus, pseudotyped viruses, and circulating SARS-CoV-2 variants. To improve their efficacy, various configurations of Nbs are engineered. Nb15-NbH-Nb15, a trimer constituted of three Nbs, is constructed to be bispecific for human serum albumin (HSA) and RBD of SARS-CoV-2. Nb15-NbH-Nb15 exhibits single-digit ng/ml neutralization potency against the wild-type and Delta variants of SARS-CoV-2 with a long half-life in vivo. In addition, we show that intranasal administration of Nb15-NbH-Nb15 provides effective protection for both prophylactic and therapeutic purposes against SARS-CoV-2 infection in transgenic hACE2 mice. Nb15-NbH-Nb15 is a potential candidate for both the prevention and treatment of SARS-CoV-2 through respiratory administration., Graphical abstract, Wu et al. report Nb15-NbH-Nb15 with a heterotrimeric bispecific configuration, which exhibits potent neutralization potency against SARS-CoV-2 and its variants, including the prevalent Delta variant, in vitro and provides in vivo protection against SARS-CoV-2 infection in hACE2 transgenic mice by intranasal delivery.

Severe fever with thrombocytopenia syndrome virus (SFTSV) is a novel tick-borne bunyavirus that recently emerged in East Asian countries. SFTS is characterized by high fever, thrombocytopenia, leukopenia, multiorgan failure, and hemorrhage with case fatality rates of 6.3% to 30%. Neither antivirals nor vaccines are available at present. We previously demonstrated that neutralizing antibodies specific for SFTSV glycoprotein (Gn) played a vital role in the survival of patients with SFTS. Nanobodies from camels present unique properties, such as thermostability, high affinity, and low immunogenicity. In the current study, mammalian expressed SFTSV Gn was used to immunize a camel, and functional nanobodies were isolated from the B cell nanobody library constructed from the immunized animal. Clone SNB02 was selected for in-depth analysis for its inhibition of SFTSV replication both in vitro and in vivo. We showed that SNB02 potently inhibited SFTSV infection and prevented thrombocytopenia in a humanized mouse model and is a potential candidate for therapeutics.

A chiral phosphoric acid promoted enantioselective NMR recognition and determination of indoloquinazoline alkaloids phaitanthrin A, cephalanthrin-A and their analogues was described, which conveniently reveals their optical purities with high accuracy. Besides, pyrazine type tertiary alcohols, cyclic amino alcohols and diamines can also be well resolved under optimal conditions. Importantly, this methodology was further employed in the direct analysis of reaction mixtures of amino acid metal salt catalyzed asymmetric synthesis of phaitanthrin A, providing access to the optimized reaction conditions in high efficiency.

The Ebola virus is highly infectious and characterized by hemorrhagic fever, headache, and so on with a high mortality rate. Currently, there are neither therapeutic drugs or vaccines against the Ebola virus nor fast diagnostic methods for the detection of Ebola virus infection. This study reported the induction and isolation of two monoclonal antibodies that specifically recognized the glycoprotein (GP) and secreted glycoprotein (sGP) of the Ebola virus. Plasmids encoding either GP or sGP were constructed and immunized BALB/c mice, accordingly purified sGP was boosted. The antisera were analyzed for binding activity against sGP protein in enzyme-linked immunosorbent assay (ELISA) and neutralization activity in a pseudotyped virus neutralization assay. A number of reactive clones were isolated and two monoclonal antibodies T231 and T242 were identified to react with both GP and sGP. Western blot and ELISA assays showed that the monoclonal antibodies could react with GP and sGP, respectively. Moreover, they could recognize Ebola pseudovirus by cellular immunochemistry assay. We labeled the monoclonal antibody T231 with biotin and analyzed the competitiveness of the two antibodies by the ELISA test. The results showed that the binding epitopes of the two monoclonal antibodies to sGP were partially overlapped. In summary, two GP-specific mAbs were identified, which will be used to detect the Ebola virus or investigate GP.

A chiral phosphoric acid promoted enantioselective NMR recognition and determination of indoloquinazoline alkaloids phaitanthrin A, cephalanthrin-A and their analogues was described, which conveniently reveals their optical purities with high accuracy. Besides, pyrazine type tertiary alcohols, cyclic amino alcohols and diamines can also be well resolved under optimal conditions. Importantly, this methodology was further employed in the direct analysis of reaction mixtures of amino acid metal salt catalyzed asymmetric synthesis of phaitanthrin A, providing access to the optimized reaction conditions in high efficiency.

A supercritical assisted drying (SAD) process was employed to produce insulin submicroparticles from an ethanol/water solution. The effect of the processing conditions on the morphology, size, and thermodynamic activity of the produced particles was investigated. Insulin particles generated from the process were generally spherical with average sizes between 0.4 and 1.1 µm. FTIR, HPLC, the Lowry method, and DTA–TG were implemented to investigate the thermodynamic activity and solvent residue of the produced particles. Results showed that the ethanol content of the aqueous solution had a more sensitive effect on the thermodynamic activity of the insulin particles than other operating factors; a high content of ethanol tended to denature the insulin particles. A rapid expansion of supercritical solutions (RESS)–SAD combined process was proposed to produce insulin–tripalmitin composite particles. Results indicated that irregular composite particles with insulin content of 33.1%, having a bimodal particle siz...

Adsorption of 2-phenylethyl alcohol (PEA) from supercritical CO 2 onto silica aerogel was investigated. A monolayer to multilayer adsorption isotherm was observed, measured at 15.0 MPa and 323.2 K, from the PEA-unsaturated to PEA-saturated supercritical CO 2 , indicating the potential utility of the solute-saturated supercritical adsorption (SSA) . The amount of PEA adsorbed on the silica aerogel with SSA at different temperatures and pressures was measured, and the release of PEA from the aerogel at 303.2 K was also evaluated. A theoretical model for the SSA equilibrium was developed with the assistance of the adsorption isotherms of pure CO 2 onto the silica and considering a three-phase binary system, where the two-dimensional van der Waals equation of state and the three-dimensional Stryjek–Vera modification of the Peng–Robinson equation of state were used respectively to describe the adsorbed phase and the bulk phases (vapor phase and liquid phase). Results showed that the model was capable of describing the adsorption behavior of the system with an average absolute relative deviation of 3.3%.

A color transparent screen was designed in this paper, utilizing a planar glass combined with lens array holographic optical elements (HOEs). The lens array HOEs were exposed using two coherent beams, one of which was the reference wave directly illuminating on the holographic material and the other was modulated by the micro lens array. The lens array HOEs can display the images with see-through abilities. Unlike the conventional ones that used the lens array HOEs as the screen solely, planar glass was adopted here as the waveguide. The projecting light was totally internalreflected in the planar glass to eliminate undesired zero-order diffracted light and realize high system compactness. Colorful display can be realized in our system as the holographic materials were capable for multi-wavelength display. To verify the effectiveness of this method, a color transparent screen incorporating the lens array HOEs and waveguide was designed. Results showed the circular display area with 20mm in diameter and the pixel resolution of 100μm were achieved in the system. This simple and effective method could be an alternative in the augment reality (AR) applications, such as transparent phone and television.

Ultrashort laser pulse has been widely used in various applications. Its parameters, such as the pulse duration and the spectral bandwidth, should be controlled accurately in order to achieve high spatial and temporal resolution, as well as high local field intensity. In this paper, we have proposed a method to trace the propagation of ultrashort pulses through optical systems, especially the complex optics. The approach, in which both the material’s dispersion and optical aberrations are taken into consideration, is developed based on the geometrical ray-tracing combined with wave theories. This method is validated by simulating the propagation of a femtosecond pulse through a specific practical imaging system. As the numerical result shows that the spatial-temporal performances of pulses are influenced greatly by optical elements, the calibration arrangement is employed to compensate for those undesired distortions. The negative dispersion of the optical grisms (the combination of gratings and prisms) is utilized in the calibration process to offset the positive dispersion introduced by lenses. The final result shows effectiveness of the correction.

For surgical light, it is important to help surgeons easily identify specific tissues. A spectrally controllable lighting environment system was established to develop visual and cognitive performance of LED lighting on people in medical environments.

Based on 3D Fourier ptychography imaging technique, adaptive selection of illumination utilizing the relationship between Fourier spectrum and illumination angle is proposed. The method reduces almost 50% computational work and accelerates the imaging reconstruction without loss of image quality.

A design method of encoded diffractive optical element (DOE) that can realize dynamic pattern generation and information encryption is proposed.The simulation results verified the design method well.

SummaryPlatelet adhesion at sites of cardiovascular injury may facilitate leukocyte deposition. We asked if and how platelets enhance lymphocyte adhesion on different subendothelial matrix protein (SEMP)-coated surface at arterial shear stress. Hirudinised whole blood was subjected to an arterial shear rate (500 s−1) in a Cone and Plate(let) analyser (CPA) for 5 minutes using plates coated with bovine serum albumin (BSA), collagen, fibrinogen, von Willebrand factor (vWF), or fibronectin. Platelet and lymphocyte adhesion were monitored by CPA and flow cytometry. Exposure of blood to collagen, fibrinogen, and vWF-coated surfaces induced platelet activation. The most marked effect was seen with collagen-coating, which markedly enhanced the adhesion of all lymphocyte subpopulations compared to BSA-coating. Fibrinogen-coating supported both T and NK cell adhesion, while vWF-coated surface only enhanced NK cell deposition. In contrast, fibronectin enhanced neither platelet activation nor lymphocyte adhesion. Moreover, platelets preferentially facilitated adhesion of large CD4+ and CD8+ T cells and NK cells, and of small B cells. Enhanced cell adhesion of larger lymphocytes was associated with elevated platelet conjugation and higher lymphocyte expression of PSGL-1, Mac-1, and CD40L. The enhancement of lymphocyte adhesion was totally platelet-dependent, and was abolished in platelet-depleted blood. Moreover, blockade of the platelet adhesion molecules P-selectin, GPIIb/IIIa, and CD40L attenuated platelet-dependent lymphocyte deposition. In conclusion, platelets support lymphocyte adhesion on SEMP-coated surfaces under arterial shear. The enhancement is selective for large T and NK cells and small B cells.

The present study characterized platelet secretion and surface expression of proangiogenic stromal cell-derived factor-1α (SDF-1α) and vascular endothelial growth factor (VEGF) and antiangiogenic PF4 and endostatin on activation. The angiogenic factors presented in randomly distributed granules in resting platelets, which were peripherized on activation. Confocal and immunogold electron microscopy demonstrated that SDF-1α/CXCL12 and PF4/CXCL4 mostly present in different granules. Platelet activation induced marked SDF-1α and endostatin but mild PF4 or no VEGF surface expression. PAR1-activating peptide (PAR1-AP), adenosine diphosphate (via P2Y1/P2Y12), and glycoprotein VI-targeting collagen-related peptide induced massive SDF-1α and VEGF but modest PF4 or no endostatin release. In contrast, PAR4-AP triggered marked PF4 and sole endostatin release but limited SDF-1α or VEGF secretion. Distinct platelet release of SDF-1α and endostatin involved different engagements of intracellular signaling pathways. In conclusion, different platelet stimuli evoke distinct secretion and surface expression of proangiogenic and antiangiogenic factors. PAR1, adenosine diphosphate, and glycoprotein VI stimulation favors proangiogenic, whereas PAR4 promotes antiangiogenic, factor release.

SummaryLymphocytes are present in atherosclerotic lesion. We hypothesise that platelets may facilitate lymphocyte infiltration into the arterial wall. Reconstituted human blood or whole blood was perfused through a collagen-coated parallel-plate flow chamber at different shear rates. Adhered platelets markedly enhanced lymphocyte adhesion that increased lymphocyte deposition from 10 ± 3 cells/mm2 of platelet-depleted blood to 38 ± 11 cells/mm2 of platelet-containing blood at the arterial shear rate of 500 s-1. Platelet-dependent lymphocyte adhesion was inhibited by P-selectin, CD40L, and GPIIb/IIIa-blocking agents, suggesting the involvement of multiple adhesion molecules in this heterotypic interaction. Lymphocyte deposition was more marked among T cells, and seen in both small and large cells. B and natural killer cell adhesion was, however, mainly seen in small cells. Platelet-conjugation facilitated lymphocyte adhesion, as suggested by the selective deposition of platelet-conjugated lymphocytes. In a mouse model of arterial thrombosis, FeCl3-induced thrombus formation markedly enhanced lymphocyte adhesion and infiltration into platelet thrombi, which was abolished by GPIIb/IIIa inhibition. In conclusion, platelets support lymphocyte adhesion under arterial flow conditions, which is selective among T cells and involves multiple adhesion molecules. Our data imply that platelets may facilitate the recruitment of circulating lymphocytes at the arterial injured sites.

Encapsulation of menthol in beeswax was prepared by a modified particles from gas-saturated solutions (PGSS) process with controlling the gas-saturated solution flow rate. Menthol/beeswax particles with size in the range of 2–50 μm were produced. The effects of the process conditions, namely, the pre-expansion pressure, pre-expansion temperature, gas-saturated solution flow rate, and menthol composition, on the particle size, particle size distribution, and menthol encapsulation rate were investigated. Results indicated that in the range of studied conditions, increase of the pressure, decrease of the gas-saturated solution flow rate, and decrease of the menthol mass fraction can decrease the particle size and narrow particle size distribution of the produced menthol/beeswax microparticles. An N2-blowing method was proposed to measure the menthol release from the menthol/beeswax microparticles. Results showed that the microparticles have obvious protection of menthol from its volatilization loss.

SummaryATP released by activated platelets can serve as a positive feedback machinery to amplify platelet responses by activating P2X1 receptors. It has, however, not been defined how P2X1 activities influence thromboxane A2 (TXA2)-stimulated platelet functional responses. Our aim was to elaborate the molecular mechanisms of P2X1 engagements in TXA2-induced platelet secretion and aggregation. P2X1 inhibition by 1 µM NF449 inhibited platelet P-selectin expression induced by a low concentration of the TXA2 analogue U46619 (0.3 µM) (32.0 ± 2.0% vs 43.4 ± 3.0%; n=5; p

SummaryAtherosclerosis is an inflammatory and thrombotic disease. Both platelets and lymphocytes play important roles in atherogenesis. However, information on their interaction is limited. We therefore studied how platelets regulate CD4+ T cell activation and differentiation. Human CD4+ T cells and autologous platelets were co-cultured. Platelets concentration-dependently enhanced anti-CD3/CD28-induced IFNγ production by CD4+ T cells, but attenuated their proliferation. Abrogation of heterotypic cell-cell contact partially reversed the enhancement, and supernatant from activated platelets partially mimicked the enhancement, suggesting that platelets exert their effects via both soluble mediators and direct cell-cell contact. Platelets enhanced the production of IL-10 and cytokines characteristic for type 1 T helper (TH1) (IFNγ/ TNFα) and TH17 (IL-17) cells, but influenced TH2 cytokines (IL-4/IL-5) little. The cytokine responses were accompanied by enhanced TH1/TH17/TReg differentiation. Using neutralising antibodies and recombinant PF4, RANTES, and TGFβ, we found that platelet-derived PF4 and RANTES enhanced both pro- and anti-inflammatory cytokine production, whilst recombinant TGFβ enhanced IL-10 but not TNFα production. In conclusion, platelets enhance the differentiation and cytokine production of anti-CD3/CD28-stimulated CD4+ T cells via both multiple chemokines and direct cell-cell contact. Our study provides new insights into the cross-talk between thrombosis and adaptive immunity, and indicates that platelets can enhance T-effector cell development.